Use of Terlipressin in AKI Associated with Hepatorenal Syndrome: CON

被引:0
|
作者
Willows, Jamie [1 ]
Hiremath, Swapnil [2 ,3 ]
机构
[1] Sunderland Royal Hosp, Renal Serv, Sunderland, England
[2] Univ Ottawa, Dept Med, Ottawa, ON, Canada
[3] Ottawa Hosp, Ottawa, ON, Canada
来源
KIDNEY360 | 2024年 / 5卷 / 06期
关键词
AKI; PLUS ALBUMIN;
D O I
10.34067/KID.0000000000000344
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:795 / 798
页数:4
相关论文
共 50 条
  • [1] Use of Terlipressin in AKI Associated with Hepatorenal Syndrome: PRO
    Belcher, Justin M.
    KIDNEY360, 2024, 5 (06): : 791 - 794
  • [2] Use of Terlipressin in AKI Associated with Hepatorenal Syndrome: COMMENTARY
    Allegretti, Andrew S.
    KIDNEY360, 2024, 5 (06): : 799 - 801
  • [3] The Use of Terlipressin in Hepatorenal Syndrome
    Rozov-Ung, Inna
    Panesar, Mandip
    DIALYSIS & TRANSPLANTATION, 2010, 39 (10) : 420 - 426
  • [4] Terlipressin for hepatorenal syndrome
    Gluud, Lise Lotte
    Christensen, Kurt
    Christensen, Erik
    Krag, Aleksander
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2012, (09):
  • [5] Terlipressin in Hepatorenal Syndrome
    Mazur, Joseph E.
    Cooper, Tanna B.
    Dasta, Joseph F.
    ANNALS OF PHARMACOTHERAPY, 2011, 45 (03) : 380 - 387
  • [6] Terlipressin in hepatorenal syndrome
    Barrueco, Nelida
    Miranda, Alberto
    Duran, Esther
    Martinez, Cecilia
    Perez, Cristina
    Sanjurjo, Maria
    PHARMACY WORLD & SCIENCE, 2007, 29 (05): : 506 - 507
  • [7] Terlipressin for hepatorenal syndrome
    Wong, Florence
    CURRENT OPINION IN GASTROENTEROLOGY, 2024, 40 (03) : 156 - 163
  • [8] Terlipressin for hepatorenal syndrome
    Gluud, L. L.
    Kjaer, M. S.
    Christensen, E.
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2006, (04):
  • [9] Terlipressin use in hepatorenal syndrome - Aa case series
    Kwan, Kah-Wai Clarence
    Chang, Pik-Eu Jason
    Tan, Chee-Kiat
    Krishnamoorthy, Thinesh Lee
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2017, 32 : 157 - 157
  • [10] Terlipressin (Terlivaz) for Hepatorenal Syndrome
    不详
    MEDICAL LETTER ON DRUGS AND THERAPEUTICS, 2023, 65 (1672): : 46 - 48